Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main Protease. (2022)

First Author: Thun-Hohenstein STD

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cmdc.202100582

PubMed Identifier: 34850566

Publication URI: http://europepmc.org/abstract/MED/34850566

Type: Journal Article/Review

Volume: 17

Parent Publication: ChemMedChem

Issue: 4

ISSN: 1860-7179